This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in


Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • anti-HBsAg indicates clinical recovery and immunity to hepatitis B virus
  • anti-HBsAg may also occur (via passive transfer) after transfusion
  • this antibody is found in about 80% of patients after clinical cure
  • anti-HBsAg may take several weeks or months to appear following the disappearance of HBsAg
  • in fulminant hepatitis the anti-HBsAg is produced early and may co-exist with low antigen titre
  • in chronic carriers - no antibody is present but antigen titres are high
  • the presence of anti-HBsAg without HBsAg detectable signifies:
    • recovery from HBV infection
    • absence of infectivity
    • immunity from future HBV infection
    • the presence of anti-HBsAg can be used to show effectivity of immunisation programme

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.


Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.